NEW YORK (AP) — Johnson & Johnson is recalling about 200,000 syringes of the anemia drug Eprex because of inconsistent potency in dosages.There were no reports of any adverse events, according to Stefan Gijssels, spokesman for the company's Janssen Pharmaceuticals division.
Saturday, September 24, 2011
Johnson & Johnson recalls anemia drug Eprex in 17 countries for inconsistent potency - OrlandoSentinel.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment